Rankings
▼
Calendar
HRTX FY 2024 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
HRTX
Heron Therapeutics, Inc.
$162M
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$144M
+13.6% YoY
Gross Profit
$106M
73.2% margin
Operating Income
-$12M
-8.0% margin
Net Income
-$14M
-9.4% margin
EPS (Diluted)
$-0.09
Cash Flow
Operating Cash Flow
-$23M
Free Cash Flow
-$24M
Stock-Based Comp.
$13M
Balance Sheet
Total Assets
$233M
Total Liabilities
$267M
Stockholders' Equity
-$34M
Cash & Equivalents
$26M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$144M
$127M
+13.6%
Gross Profit
$106M
$62M
+70.6%
Operating Income
-$12M
-$111M
+89.6%
Net Income
-$14M
-$111M
+87.7%
← Q4 2023
All Quarters
Q1 2024 →